Journal of the American Academy of Dermatology
Volume 40, Issue 6 , Pages 930-937 , June 1999

Finasteride in the treatment of men with frontal male pattern hair loss

These data were originally presented at Dermatology 19th World Congress, Australia, June 1997.

,Accepted 8 January 1999.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ The reported clinical study was entirely supported by Merck Research Laboratories, Merck & Co, Inc. Merck & Co, Inc is the company that manufactures and markets finasteride.

☆☆ A full conflict of interest statement from each of the authors has been submitted to the Editor. One or more of the authors have received payment for conducting the study, acted as consultants to the sponsoring company, received honoraria for lecturing, or owned stock in the sponsoring company.

★ Reprint requests: Joanne Waldstreicher, MD, Clinical Research RY33-508, Merck Research Laboratories, 126 E Lincoln Ave, Rahway, NJ 07065.

★★ 0190-9622/99/$8.00 + 0  16/1/96937

PII: S0190-9622(99)70081-2

Journal of the American Academy of Dermatology
Volume 40, Issue 6 , Pages 930-937 , June 1999

Article Tools

* Image Usage & Resolution